-
Drug Repurposing for Cancer: How Old Drugs Are Becoming New Treatments (2026)
Here’s the short version: drug repurposing — also called drug repositioning or drug reprofiling — means taking a medicine that’s already approved for one condition and finding a new job for it. In oncology, that includes antipsychotics, anti-inflammatory drugs, antivirals, diabetes drugs, antibiotics, and even antifungals. None of them were designed to fight cancer. Some of them, it turns out, are pretty good at it anyway. The best part? These drugs already have safety data. Researchers know their dosing, their side effects, how the body breaks them down. That means they can reach patients far faster — and at a fraction of the cost — than anything built from scratch.…
-
Drug Repurposing for Antimicrobial Resistance: Turning Old Drugs Into New Weapons
The numbers hit hard. In 2019, bacterial antimicrobial resistance directly killed 1.27 million people. That’s more than HIV or malaria. And it contributed to nearly 5 million deaths overall. By 2050, if we keep going the way we are, we could hit 10 million deaths a year from resistant infections. The WHO has been shouting from the rooftops for years, but the pipeline for new antibiotics is still dangerously thin. There’s a reason for that, and it’s not just about the science. Developing a new antibiotic costs somewhere north of $1.6 billion and takes 10 to 17 years. And here’s the kicker: antibiotics are prescribed in short courses and held…
